TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/22/20 19:51 | 12/21/20 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin John Peter | NV | D | S.m | -856 | 2.61 | 0 | -328 | -62 | 200 | D | |||||||||||||||
9/13/11 17:04 | 9/9/11 | SGEN | Seattle Genetics Inc /wa | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin John Peter | WA | D | M.d | 246 | 9.82 | 33 | 25 | New | 25 | D | 26 | 44 | 20 | -10 | 7 | 19 | 1 | -2 | 0 | 4 | 17 | -2 | 2 | 54 | |
9/16/09 20:01 | 9/15/09 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McLaughlin John Peter | NV | DO | P,CEO | M.d | 154 | 5.41 | 26 | 28 | 59 | 76 | D | -2 | 34 | 41 | 22 | 6 | -1 | 3 | 3 | 1 | -3 | 5 | 4 | 5 | -9 |
8/11/04 12:03 | 8/11/04 | CGTK | Corgentech Inc | DE | Health | Drug | Pharmaceutical Preparations | McLaughlin John Peter | CA | DO | P,CEO | M.d | 12 | 1.20 | 0 | 10 | 3 | 310 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |